Enterprise Cloud Readiness Viome is pursuing enterprise-grade health data deployments via a Microsoft Azure integration, enabling secure, scalable hosting of its RNA and microbiome insights for partners. This creates opportunities to sell to large employers, insurers, digital clinics, and healthcare systems seeking integrated wellness programs.

Dental Health Channel Viome's dental health initiatives, including VRx MyBiotics toothpaste and a Henry Schein distribution agreement for Oral Health Pro with CancerDetect, open channels in dental practices and supply networks to cross-sell microbiome diagnostics and cancer-detecting oral care.

Consumer Product Expansion The consumer product launch and AI-powered diagnostics broaden Viome beyond testing into a continuous health journey, creating sales opportunities with insurers, employers, fitness and wellness brands for embedded personalized nutrition programs.

Growth & Leadership Recent leadership appointments and a Series D round signal strong growth as Viome scales its consumer business; leverage this momentum to pursue strategic partnerships, co-development deals, and potential future funding rounds.

Data Asset Platform Viome's unique data asset — a large dataset of human and microbial gene expression with exclusive licensing — plus a cloud-native platform supports data licensing, API integrations, and collaboration with researchers, healthcare providers, and life sciences firms.